This trial is testing a new treatment for metastatic melanoma that has spread to the liver. The treatment is a combination of radiation and two immunotherapy drugs. The goal is to see if this new treatment is effective and tolerated by patients.
1 Primary · 6 Secondary · Reporting Duration: Up to 5 weeks after start of study treatment
18 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic Body Radiation Therapy · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: